To confirm the relationship between ZNF267 and EMT as well as CSC properties, we conducted the immunoblotting assay on FARAGE and OCI-LY3 cells with ZNF267 knockdown, and IHC assay on xenograft tumor tissues to detect the expression of related proteins. Here, ZNF267 is linked to neoplasm.